KEY TAKEAWAYS Insulin resistance can be tested through fasting insulin and glucose ratios, even in countries where insulin testing is less common Rapid weight loss rates above 15% annually may indicate no need for dose increases Severe GI side effects warrant investigation beyond medication adjustment, including gallbladder evaluation DEXA scans provide valuable visceral fat measurements, but results should be interpreted alongside overall health markers Maintenance strategies should focus on nutritional stability before considering medication tapering NOTABLE QUOTE "It's not that the medicine causes the rebound weight gain, it's that with the medication in there, the body is getting better signals, and then you go and take the medication away and you're in the same boat." Dr
Nanotechnology delivers a therapeutic dose at a fraction of the weight
Indirect effects are mediated mainly through IGF-1 (insulin-like growth factor 1), which is produced in the liver and other tissues in response to GH boost
7d, the tumor tissues from mice treated with BMS-754807 + U0126 showed the least Ki-67 and the most TUNEL comparing to the tumors from the mice treated with vehicle control, BMS-754807, or U0126
This was after U.S
Wegovy is more helpful for those patients who need to lose weight and maintain it for an extended period of time or who need to change their eating habits significantly
